Drug-induced methaemoglobinaemia following elective coronary artery bypass grafting

Anaesthesia

Volumn 62, Issue 7, 2007, Pages 737-740

  Choi, A ^a   Sarang, Amman ^b  

^a BROOMFIELD HOSPITAL   (United Kingdom)

^b LONDON CHEST HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; DAPSONE; DIHYDROCODEINE; ETOMIDATE; FENTANYL; ISOFLURANE; METHEMOGLOBIN; NALOXONE; NONSTEROID ANTIINFLAMMATORY AGENT; OXYGEN; ROCURONIUM;

ADULT; ANEMIA; ANESTHESIA INDUCTION; ARTICLE; BACKACHE; BLOOD GAS ANALYSIS; BLOOD PRESSURE MONITORING; BRADYPNEA; CARBON DIOXIDE TENSION; CASE REPORT; COMORBIDITY; CONSCIOUSNESS DISORDER; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DROWSINESS; DRUG WITHDRAWAL; ELECTIVE SURGERY; ENDOTRACHEAL INTUBATION; FEMALE; HEART DISEASE; HUMAN; KIDNEY DISEASE; KIDNEY FAILURE; LONG TERM CARE; METHEMOGLOBINEMIA; OPERATION DURATION; OXYGEN SATURATION; OXYGEN SUPPLY; OXYGEN TENSION; PHYSIOTHERAPY; POSITIVE END EXPIRATORY PRESSURE; POSTOPERATIVE CARE; PROTEIN BLOOD LEVEL; PULSE OXIMETRY; RESPIRATORY TRACT DISEASE; STERNOTOMY;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIOXIDANTS; ASCORBIC ACID; CORONARY ARTERY BYPASS; DAPSONE; FEMALE; HUMANS; HYPOXIA, BRAIN; METHEMOGLOBINEMIA; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS;

EID: 34250625258     PISSN: 00032409     EISSN: 13652044     Source Type: Journal    
DOI: 10.1111/j.1365-2044.2007.05000.x     Document Type: Article

References (14)

1. Groeper K, Katcher K, Tobias J. Anesthetic management of a patient with methemoglobinemia. Southern Medical Journal 2003; 96: 504-9.
2. Szeremeta W, Dohar JE. Dapsone-induced methemoglobinemia: An anesthetic risk. International Journal of Pediatric Otorhinolaryngology 1995; 33: 75-80.
3. Galose A. Dapsone (diaminodiphenylsulphone, DDS). Clinical Toxicology Review, Massachusetts Poison Contrological System 1999; 21: 1-3.
4. Sprung J, Bourke DL, Mackenzie CF, Thomas P. Chronic methemoglobinemia: Improving hemoglobin saturation monitoring during anesthesia. Journal of Clinical Monitoring 1994; 10: 267-9.
5. Coleman MD, Coleman NA. Drug-induced methaemoglobinaemia. Treatment issues. Drug Safety 1996; 14: 394-405.
6. Van Heijst NP. Methaemoglobinaemia. IPCS INTOX Databank, 2003.
7. Wright RO, Lewander WJ, Woolf AD. Methemoglobinemia: Etiology, pharmacology, and clinical management. Annals of Emergency Medicine 1999; 34: 646-56.
8. Hall AH, Kulig KW, Rumack BH. Drug- and chemical-induced methaemoglobinameia. Clinical features and management. Medical Toxicology 1986; 1: 253-60.
9. Bradberry SM. Occupational methaemoglobinaemia. Mechanisms of production, features, diagnosis and management including use of methylene blue. Toxicology Review 2003; 22: 13-27.
10. Borowicz LM, Goldsborough MA, Selnes OA, McKhann GM. Neuropsychologic change after cardiac surgery: A critical review. Journal of Cardiothoracic and Vascular Anesthesia 1996; 10: 105-12.
11. Hogue CW, Sundt TM, Goldberg M, Barner H, Davila-Roman VG. Neurological complications of cardiac surgery: The need for new paradigms in prevention and treatment. Seminars in Thoracic and Cardiovascular Surgery 1999; 11: 105-15.
12. Nussmeier N. A review of risk factors for adverse neurologic outcome after cardiac surgery. Journal of the American Society of Extra-Corporeal Technology 2002; 34: 4-10.
13. Taggart DP, Westaby S. Neurological and cognitive disorders after coronary artery bypass grafting. Current Opinion in Cardiology 2001; 16: 271-6.
14. O'Dwyer C, Prough DS, Johnston WE. Determinants of cerebral perfusion during cardiopulmonary bypass. Journal of Cardiothoracic and Vascular Anesthesia 1996; 10: 54-65.